Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The French pharmacovigilance surveys: A French distinctiveness, a real input.
Abou Taam M, Jacquot B, Ferard C, Thery AC, Mounier C, Grandvuillemin A, Jonville-Béra AP, Perault-Pochat MC; Réseau français des centres régionaux de pharmacovigilance. Abou Taam M, et al. Therapie. 2021 Sep-Oct;76(5):441-447. doi: 10.1016/j.therap.2020.05.011. Epub 2020 May 24. Therapie. 2021. PMID: 32553501
The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza.
Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, Zenut M, Disson-Dautriche A, Logerot S, Auffret M, Coubret-Dumas A, Bruel ML, Boyer M, Bos-Thompson MA, Veyrac G, Carlier P, Beyens MN, Lates S, Damase-Michel C, Castot A, Kreft-Jaïs C, Pérault-Pochat MC. Chavant F, et al. Drug Saf. 2013 Jun;36(6):455-65. doi: 10.1007/s40264-013-0030-1. Drug Saf. 2013. PMID: 23516007
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
Laroche ML, Perault-Pochat MC, Ingrand I, Merle L, Kreft-Jais C, Castot-Villepelet A, Durrieu G, Gras V, Guy C, Jean-Pastor MJ, Jonville-Béra AP, Merlet-Chicoine I, Miremont-Salamé G, Nourhashemi F, Charmes JP; French Centres of Pharmacovigilance Network. Laroche ML, et al. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):952-60. doi: 10.1002/pds.3471. Epub 2013 Jun 24. Pharmacoepidemiol Drug Saf. 2013. PMID: 23794320 Clinical Trial.
Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment.
Moulis G, Bagheri H, Sailler L, Jonville-Bera AP, Weber E, Guy C, Petitpain N, Laroche ML, Favrelière S, Béné J, Baldin B, Villeval-Federici L, Tebacher-Alt M, Bres V, Veyrac G, Grandvuillemin A, Mauprivez C, Lapeyre-Mestre M, Montastruc JL; French Association of PharmacoVigilance Centers. Moulis G, et al. Eur J Intern Med. 2014 Oct;25(8):777-80. doi: 10.1016/j.ejim.2014.09.006. Epub 2014 Sep 18. Eur J Intern Med. 2014. PMID: 25242516
220 results